B

Fakespot review grade

B

This analysis is outdated. Please reanalyze.

Ask Fakespot Chat questions about this productAlpha

Initializing Fakespot Chat

System error,

Loading suggested questions

Suggested Questions

No suggested questions were found

Please note: The content is generated by an AI language model based on reviews. We are constantly improving the accuracy, however, its outputs may contain errors or offensive content from certain reviews. Please report any errors or offensive content to us. Also, please note that we will not collect your questions unless you click the thumbs up/down button to provide feedback. The answers displayed will be stored by us so if another Fakespotter asks a similar question we can provide them an answer faster. Your feedback will only help us make Fakespot Chat better! By using Fakespot Chat, you agree to Fakespot's terms of use and privacy notice.

Pros & Cons

Update Pros and Cons

The AI used to provide these results are constantly improving. These results might change.

Cons

The taste of these is just awful. My son typically has no problem taking pills of all sizes but this was impossible.

Was this feature helpful?

Highlights

The AI used to provide these results are constantly improving. These results might change.

Quality

Good quality chewables, calm, brain function seems better, easier to read.

Remarkable product that elevates symptoms for acute anxiety

Sarcosine prevents schizophrenic deformation of the human brain from marijuana use.

Able to be more patient with family member with ocd and early dementia- i used to be miserable and frustrated.

Price

They are expensive, but like i said, they seem to be helping, so for now, i'll keep taking just the one a day.

Overview

How are reviewers describing this item?
past, emotional and far.

Our engine has profiled the reviewer patterns and has determined that there is minimal deception involved.

Our engine has discovered that over 80% high quality reviews are present.

This product had a total of 121 reviews as of our last analysis date on Feb 27 2024.